Crossmark

AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression

Crossref DOI link: https://doi.org/10.1038/onc.2015.357

Published Online: 2015-10-05

Published Print: 2016-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Felli, N

Errico, M C

Pedini, F

Petrini, M

Puglisi, R

Bellenghi, M

Boe, A

Felicetti, F

Mattia, G

De Feo, A

Bottero, L

Tripodo, C

Carè, A
License Information

Text and Data Mining valid from 2015-10-05
More Information

Article History

Received: 10 April 2015

Revised: 6 August 2015

Accepted: 24 August 2015

First Online: 5 October 2015

Competing interests

: The authors declare no conflict of interest.